This study investigated the anti-inflammatory effect of clodronate, a vesicular nucleotide transporter (VNUT) inhibitor, on intestinal-failure-associated liver disease (IFALD) in a rat model of short bowel syndrome (SBS). Here, SLC17A9 is linked to macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.